Page last updated: 2024-08-24

capecitabine and fenoxycarb

capecitabine has been researched along with fenoxycarb in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duncton, MA; Emerling, DE; Kelly, MG; Nguyen, MT; Vincent, F1
Gong, Y; Li, GF; Yu, G1
Chu, MP; Sawyer, MB1
Gu, W; Shan, B; Wang, L1
Hussaarts, KGAM; Mathijssen, RHJ; van Leeuwen, RWF1

Other Studies

5 other study(ies) available for capecitabine and fenoxycarb

ArticleYear
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
    Bioorganic & medicinal chemistry letters, 2009, Dec-01, Volume: 19, Issue:23

    Topics: Amidohydrolases; Carbamates; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Piperazines; Stereoisomerism; Structure-Activity Relationship

2009
Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer.
    JAMA oncology, 2018, 02-01, Volume: 4, Issue:2

    Topics: Capecitabine; Esophageal Neoplasms; Humans; Logic; Proton Pump Inhibitors; Stomach Neoplasms

2018
Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer-Reply.
    JAMA oncology, 2018, 02-01, Volume: 4, Issue:2

    Topics: Capecitabine; Esophageal Neoplasms; Humans; Logic; Proton Pump Inhibitors; Stomach Neoplasms

2018
Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer.
    JAMA oncology, 2018, 02-01, Volume: 4, Issue:2

    Topics: Capecitabine; Esophageal Neoplasms; Humans; Logic; Proton Pump Inhibitors; Stomach Neoplasms

2018
Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer.
    JAMA oncology, 2018, 02-01, Volume: 4, Issue:2

    Topics: Capecitabine; Esophageal Neoplasms; Humans; Logic; Proton Pump Inhibitors; Stomach Neoplasms

2018